Clindagel
Product Images NDC 16781-462

2 FDA label images from Bausch Health Us, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindagel (NDC 16781-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (70272df5 Dd46 4060 Bed1 F89a7e8a6121 00)

Chemstructure (70272df5 Dd46 4060 Bed1 F89a7e8a6121 00)
Chemical structure of clindamycin, the active ingredient in Clindagel 10 mg/mL topical gel by Bausch Health US, LLC. The structure shows carbon, hydrogen, nitrogen, oxygen, phosphorus, sulfur, and chlorine atoms arranged in its characteristic molecular framework.*
FDA Label Image

Carton (Image 02)

Carton (Image 02)
The packaging label for Clindagel 1% topical gel, containing clindamycin phosphate equivalent to 1% clindamycin in a 75 mL tube. The label specifies it is for topical use only and external use. It includes usage instructions, storage conditions, and manufacturer information for Bausch Health US, LLC, and Bausch Health Companies Inc. The label features the Ortho Dermatologics logo and the product NDC 16781-462-75.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.